BioSpace News Archive

Genetown

AGTC to Host Conference Call and Webcast on January 9 at 8:00 am ET to Discuss X-Linked Retinitis Pigmentosa Interim Six-Month Data from the Dose Expansion Cohort of its Ongoing Phase 1/2 Clinical Trial

Applied Genetic Technologies Corporation announced that it plans to release interim six-month data from the expansion group, and an update of enrollment for its ongoing Phase 1/2 clinical trial in patients with X-linked Retinitis Pigmentosa on January 9, 2020.

January 8, 2020
·
2 min read
Business

Gritstone Oncology to Present at the 38th Annual J.P. Morgan Healthcare Conference

The company will hold a question and answer session immediately following the presentation.

January 8, 2020
·
1 min read
Biotech Beach

AnaptysBio to Present at J.P. Morgan Annual Healthcare Conference

J.P. Morgan 38th Annual Healthcare Conference on Wednesday, Jan. 15, 2020 at 2:30 p.m. PT at the Westin St. Francis in San Francisco.

January 8, 2020
·
1 min read
Business

Aeterna Zentaris Receives NASDAQ Notification Regarding Minimum Bid Price Requirement

Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.

January 8, 2020
·
5 min read
FDA

Nabriva Therapeutics Receives FDA Acknowledgement of New Drug Application Resubmission for Intravenous CONTEPO™ (fosfomycin) for InjectionPDUFA action date set for June 19, 2020

In the acknowledgement letter for the resubmitted NDA, the FDA stated that Nabriva’s filing was a complete, class 2 response to the complete response letter the FDA issued on April 30, 2019.

January 8, 2020
·
5 min read
Alkermes’ Corporate Presentation to be Webcast at the 38th Annual J.P. Morgan Healthcare Conference

The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

January 8, 2020
·
1 min read
Biotech Bay

Kindred Biosciences Announces Half-Life Extension Technology for Canine Antibodies

Positive results from canine pharmacokinetic study demonstrate up to three-fold increase in antibody half-life

January 8, 2020
·
6 min read
Deals

Mirati Therapeutics Announces Proposed Public Offering of Common Stock - Jan. 8, 2020

Mirati Therapeutics, Inc. announced that it intends to offer and sell, subject to market and other conditions, $250.0 million of shares of its common stock in an underwritten public offering.

January 8, 2020
·
4 min read
Biotech Bay

Akero Therapeutics To Present At The 2020 J.P. Morgan Healthcare Conference

J.P. Morgan Healthcare Conference at 7:30 AM Pacific time on Wednesday, January 15, 2020.

January 8, 2020
·
1 min read
Genetown

Vertex to Present at the J.P. Morgan Healthcare Conference on January 13

The audio portion of management’s remarks can be accessed live through Vertex’s website, www.vrtx.com, in the “Investors” section under the “News and Events” page.

January 8, 2020
·
1 min read